Aetiology and outcome in hospitalized cardiac arrest patients.

Malin Albert, Johan Herlitz, Araz Rawshani, Sune Forsberg, Mattias Ringh, Jacob Hollenberg, Andreas Claesson, Meena Thuccani, Peter Lundgren, Martin Jonsson, Per Nordberg
{"title":"Aetiology and outcome in hospitalized cardiac arrest patients.","authors":"Malin Albert,&nbsp;Johan Herlitz,&nbsp;Araz Rawshani,&nbsp;Sune Forsberg,&nbsp;Mattias Ringh,&nbsp;Jacob Hollenberg,&nbsp;Andreas Claesson,&nbsp;Meena Thuccani,&nbsp;Peter Lundgren,&nbsp;Martin Jonsson,&nbsp;Per Nordberg","doi":"10.1093/ehjopen/oead066","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To study aetiologies of in-hospital cardiac arrests (IHCAs) and their association with 30-day survival.</p><p><strong>Methods and results: </strong>Observational study with data from national registries. Specific aetiologies (<i>n</i> = 22) of IHCA patients between April 2018 and December 2020 were categorized into cardiac vs. non-cardiac and six main aetiology categories: myocardial ischemia, other cardiac causes, pulmonary causes, infection, haemorrhage, and other non-cardiac causes. Main endpoints were proportions in each aetiology, 30-day survival, and favourable neurological outcome (Cerebral Performance Category scale 1-2) at discharge. Among, 4320 included IHCA patients (median age 74 years, 63.1% were men), approximate 50% had cardiac causes with a 30-day survival of 48.4% compared to 18.7% among non-cardiac causes (<i>P</i> < 0.001). The proportion in each category were: myocardial ischemia 29.9%, pulmonary 21.4%, other cardiac causes 19.6%, other non-cardiac causes 11.6%, infection 9%, and haemorrhage 8.5%. The odds ratio (OR) for 30-day survival compared to myocardial ischemia for each category were: other cardiac causes OR 1.48 (CI 1.24-1.76); pulmonary causes OR 0.36 (CI 0.3-0.44); infection OR 0.25 (CI 0.18-0.33); haemorrhage OR 0.22 (CI 0.16-0.3); and other non-cardiac causes OR 0.56 (CI 0.45-0.69). IHCA caused by myocardial ischemia had the best favourable neurological outcome while those caused by infection had the lowest OR 0.06 (CI 0.03-0.13).</p><p><strong>Conclusion: </strong>In this nationwide observational study, aetiologies with cardiac and non-cardiac causes of IHCA were evenly distributed. IHCA caused by myocardial ischemia and other cardiac causes had the strongest associations with 30-day survival and neurological outcome.</p>","PeriodicalId":11973,"journal":{"name":"European Heart Journal Open","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411044/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ehjopen/oead066","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: To study aetiologies of in-hospital cardiac arrests (IHCAs) and their association with 30-day survival.

Methods and results: Observational study with data from national registries. Specific aetiologies (n = 22) of IHCA patients between April 2018 and December 2020 were categorized into cardiac vs. non-cardiac and six main aetiology categories: myocardial ischemia, other cardiac causes, pulmonary causes, infection, haemorrhage, and other non-cardiac causes. Main endpoints were proportions in each aetiology, 30-day survival, and favourable neurological outcome (Cerebral Performance Category scale 1-2) at discharge. Among, 4320 included IHCA patients (median age 74 years, 63.1% were men), approximate 50% had cardiac causes with a 30-day survival of 48.4% compared to 18.7% among non-cardiac causes (P < 0.001). The proportion in each category were: myocardial ischemia 29.9%, pulmonary 21.4%, other cardiac causes 19.6%, other non-cardiac causes 11.6%, infection 9%, and haemorrhage 8.5%. The odds ratio (OR) for 30-day survival compared to myocardial ischemia for each category were: other cardiac causes OR 1.48 (CI 1.24-1.76); pulmonary causes OR 0.36 (CI 0.3-0.44); infection OR 0.25 (CI 0.18-0.33); haemorrhage OR 0.22 (CI 0.16-0.3); and other non-cardiac causes OR 0.56 (CI 0.45-0.69). IHCA caused by myocardial ischemia had the best favourable neurological outcome while those caused by infection had the lowest OR 0.06 (CI 0.03-0.13).

Conclusion: In this nationwide observational study, aetiologies with cardiac and non-cardiac causes of IHCA were evenly distributed. IHCA caused by myocardial ischemia and other cardiac causes had the strongest associations with 30-day survival and neurological outcome.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
住院心脏骤停患者的病因和转归。
目的:研究院内心脏骤停(IHCAs)的病因及其与30天生存率的关系。方法和结果:观察性研究,数据来自国家登记处。2018年4月至2020年12月期间IHCA患者的具体病因(n = 22)分为心脏与非心脏以及6个主要病因类别:心肌缺血、其他心脏原因、肺部原因、感染、出血和其他非心脏原因。主要终点是每种病因的比例、30天生存率和出院时良好的神经学预后(脑功能分类量表1-2)。在纳入的4320例IHCA患者(中位年龄74岁,63.1%为男性)中,约50%有心脏原因,30天生存率为48.4%,而非心脏原因为18.7% (P < 0.001)。各类型所占比例依次为:心肌缺血29.9%,肺部21.4%,其他心脏原因19.6%,其他非心脏原因11.6%,感染9%,出血8.5%。与心肌缺血相比,每种类型30天生存率的优势比(OR)为:其他心脏原因OR 1.48 (CI 1.24-1.76);肺部原因OR 0.36 (CI 0.3-0.44);感染OR为0.25 (CI 0.18-0.33);出血OR 0.22 (CI 0.16-0.3);和其他非心脏原因OR 0.56 (CI 0.45-0.69)。心肌缺血所致IHCA的神经系统预后最佳,感染所致IHCA的OR为0.06 (CI 0.03 ~ 0.13)。结论:在这项全国性的观察性研究中,IHCA的心源性和非心源性病因分布均匀。心肌缺血和其他心脏原因引起的IHCA与30天生存率和神经预后的相关性最强。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Changes of intracardiac flow dynamics measured by HyperDoppler in patients with aortic stenosis Development of a Small Animal Model Replicating Core Characteristics of Takotsubo Syndrome in Humans Elastin turnover in Williams Beuren and 7q11.23 microduplication syndromes Myeloid-specific interleukin-6 response: from vascular effects to the potential for novel personalized medicines Myeloid cell derived Interleukin-6 induces vascular dysfunction and vascular and systemic inflammation
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1